companies / nomy-no
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-07 json
| total_raised | 1,350,0001.4M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | Norway | |
| industry | unknown | |
| stage | seed |
NoMy is a Norwegian biotech that produces mycoprotein ingredients from filamentous fungi grown on industrial side-streams. It serves food and feed manufacturers seeking high-protein, low-footprint alternatives to soy, fishmeal, and meat. The process upcycles waste streams from beverage, dairy, and seafood industries into edible protein.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-05-01 | strategic | 1,350,0001.4M | null | ○ |
hsts, http/3, nginx, readymag, underscore.js
| fact | status | src |
|---|---|---|
| Strategic, $1.4M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |